Episode

Episode 493: The Role of Chemotherapy in mHSPC

Podcast
The Uromigos
Published
Apr 13, 2026
Duration seconds
2843
Processing state
not_requested
Canonical source
https://podcasters.spotify.com/pod/show/the-uromigos/episodes/Episode-493-The-Role-of-Chemotherapy-in-mHSPC-e3hke0d
Audio
https://anchor.fm/s/13347ea8/podcast/play/118158797/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-3-8%2F421676514-44100-2-63b619ed171f5.m4a
JSON
/v1/public/podcasts/the-uromigos-1214845/episodes/episode-493-the-role-of-chemotherapy-in-mhspc
Markdown
/podcast/the-uromigos-1214845/episode-493-the-role-of-chemotherapy-in-mhspc.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-uromigos-1214845/episodes/episode-493-the-role-of-chemotherapy-in-mhspc/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-uromigos-1214845/episode-493-the-role-of-chemotherapy-in-mhspc.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In the world of prostate cancer treatment, chemotherapy's role, especially in metastatic hormone-sensitive cases, remains a topic of much discussion and evolving understanding. In this podcast, we delve into the insights shared during a recent conversation with Dr. Deepak Kilari, a GU Medical Oncologist, exploring the nuances of chemotherapy in this context. We discuss key trials, shifting definitions of disease volume, and the implications for treatment decisions .